FCB Health chief creative officer Rich Levy analyzes six campaigns the jury debated long and hard at this year’s Cannes Lions International Festival of Creativity.
Promising rare conditions treatments could upend the market hierarchy
With less than 14% of Phase I to III drug candidates winning FDA approval, unforeseen roadblocks can derail even the most promising clinical research programs.
Akebia Therapeutics’ John Butler seeks to bring company to the forefront of renal space
Healthcare-first agencies face a challenge to find A-grade talent among the plethora of job applicants. MM&M asked HR experts at firms of all sizes what the perfect candidate looks like.
10 industry executives share their career paths and lessons learned
There’s no such thing as a “typical” career path in pharma and healthcare. Ten executives share their journeys and the lessons they learned along the way.